ARCHIVES

Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia

This article is from The Cancer Letter archive.

Vol. 26 No. 10 | October 31, 2003

Download PDF Visit The Full Archive

Related Articles

Norton Succeeds Einhorn As ASCO President, Colorado’s Paul Bunn Is President-Elect.

May 11, 2001

Carfilzomib Demonstrates Clinical Benefit Rate of 64%

December 30, 2011

Nine More Reported In Range Of CCOP 3 Recompetition

February 2, 1990

In Brief: Three NCI Basic Science Centers Rank In Index Of Citations; Novello: Help More Smokers Quit

August 2, 1991

Time Spent Sitting Associated With Total Mortality, Study Finds

July 30, 2010

Genentech Reps Not Welcome: Hospitals Urge Drug Maker to Reverse Policy On Supplying Avastin, Rituxan, & Herceptin

October 17, 2014